{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:07:44Z","timestamp":1783073264766,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program","doi-asserted-by":"crossref","award":["2014CB541801"],"award-info":[{"award-number":["2014CB541801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National key research and development program","doi-asserted-by":"crossref","award":["2016YFA0501303"],"award-info":[{"award-number":["2016YFA0501303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31521003, 31630088, 31571293"],"award-info":[{"award-number":["31521003, 31630088, 31571293"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International S&T Cooperation Program of China","award":["2013DFA30870"],"award-info":[{"award-number":["2013DFA30870"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s10020-019-0093-2","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T14:47:14Z","timestamp":1560437234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiucun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"93_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","volume":"25","author":"JN Arnold","year":"2007","unstructured":"Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25:21\u201350.","journal-title":"Annu Rev Immunol"},{"key":"93_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/ajg.2016.306","volume":"111","author":"T Billiet","year":"2016","unstructured":"Billiet T, et al. A genetic variation in the neonatal fc-receptor affects anti-TNF drug concentrations in inflammatory bowel disease. Am J Gastroenterol. 2016;111:1438\u201345.","journal-title":"Am J Gastroenterol"},{"key":"93_CR3","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s10067-014-2807-8","volume":"33","author":"R Cuchacovich","year":"2014","unstructured":"Cuchacovich R, Perez-Alamino R, Zea AH, Espinoza LR. Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors. Clin Rheumatol. 2014;33:1815\u201321.","journal-title":"Clin Rheumatol"},{"key":"93_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep28207","volume":"6","author":"SE de Jong","year":"2016","unstructured":"de Jong SE, et al. IgG1 fc N-glycan galactosylation as a biomarker for immune activation. Sci Rep. 2016;6:28207.","journal-title":"Sci Rep"},{"key":"93_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.lfs.2005.08.040","volume":"78","author":"H Kimura","year":"2006","unstructured":"Kimura H, et al. Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia. Life Sci. 2006;78:1901\u201310.","journal-title":"Life Sci"},{"key":"93_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep32202","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu J, et al. TNF-alpha promoter polymorphisms predict the response to Etanercept more powerfully than that to infliximab\/adalimumab in Spondyloarthritis. Sci Rep. 2016;6:32202.","journal-title":"Sci Rep"},{"key":"93_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3899\/jrheum.110961","volume":"39","author":"B Mesko","year":"2012","unstructured":"Mesko B, et al. Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis. J Rheumatol. 2012;39:916\u201328.","journal-title":"J Rheumatol"},{"key":"93_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/cr.2016.83","volume":"26","author":"S Ren","year":"2016","unstructured":"Ren S, et al. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types. Cell Res. 2016;26:963\u20136.","journal-title":"Cell Res"},{"key":"93_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jbspin.2013.04.004","volume":"81","author":"E Salgado","year":"2014","unstructured":"Salgado E, Maneiro JR, Carmona L, Gomez-Reino J. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies. Joint Bone Spine. 2014;81:41\u201350.","journal-title":"Joint Bone Spine"},{"key":"93_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.18553\/jmcp.2013.19.8.621","volume":"19","author":"VF Schabert","year":"2013","unstructured":"Schabert VF, et al. Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population. Journal of managed care pharmacy : JMCP. 2013;19:621\u201330.","journal-title":"Journal of managed care pharmacy : JMCP"},{"key":"93_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nrrheum.2016.42","volume":"12","author":"J Sieper","year":"2016","unstructured":"Sieper J, Poddubnyy D. New evidence on the management of spondyloarthritis. Nat Rev Rheumatol. 2016;12:282\u201395.","journal-title":"Nat Rev Rheumatol"},{"key":"93_CR12","doi-asserted-by":"crossref","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017.","DOI":"10.1093\/med\/9780199642489.003.0113_update_004"},{"key":"93_CR13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2217\/pgs.15.90","volume":"16","author":"GG Song","year":"2015","unstructured":"Song GG, et al. Association between TNF-alpha (\u2212308 a\/G, \u2212238 a\/G, \u2212857 C\/T) polymorphisms and responsiveness to TNF-alpha blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysis. Pharmacogenomics. 2015;16:1427\u201337.","journal-title":"Pharmacogenomics"},{"key":"93_CR14","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial Spondyloarthritis. N Engl J Med. 2016;374:2563\u201374.","journal-title":"N Engl J Med"},{"key":"93_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrgastro.2014.78","volume":"11","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, et al. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol. 2014;11:588\u2013600.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"93_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2217\/pgs.12.133","volume":"13","author":"Q Tong","year":"2012","unstructured":"Tong Q, et al. TNF-alpha \u2212857 and \u22121031 polymorphisms predict good therapeutic response to TNF-alpha blockers in Chinese Han patients with ankylosing spondylitis. Pharmacogenomics. 2012;13:1459\u201367.","journal-title":"Pharmacogenomics"},{"key":"93_CR17","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2217\/pgs.13.146","volume":"14","author":"Q Tong","year":"2013","unstructured":"Tong Q, et al. Association of TNF-alpha polymorphism with prediction of response to TNF blockers in spondyloarthritis and inflammatory bowel disease: a meta-analysis. Pharmacogenomics. 2013;14:1691\u2013700.","journal-title":"Pharmacogenomics"},{"key":"93_CR18","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/art.39273","volume":"67","author":"F Vuckovic","year":"2015","unstructured":"Vuckovic F, et al. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis & rheumatology. 2015;67:2978\u201389.","journal-title":"Arthritis & rheumatology"},{"key":"93_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1096\/fj.01-0533com","volume":"16","author":"B Zingarelli","year":"2002","unstructured":"Zingarelli B, et al. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2002;16:327\u201342.","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-019-0093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10020-019-0093-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-019-0093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:12:09Z","timestamp":1591917129000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-019-0093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1186\/s10020-019-0093-2","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committees of the School of Life Sciences of Fudan University and written and informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}